US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Defiance Daily Target 2X Long MRNA ETF

142.18

-0.7900-0.55%

Volume:86.20K

Turnover:12.22M

Market Cap:75.36M

PE:- -

High:147.06

Open:140.78

Low:138.07

Close:142.97

52wk High:167.89

52wk Low:14.95

Shares:530.00K

Float Shares:530.00K

Volume Ratio:1.01

T/O Rate:16.26%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Moderna stock rises 8%: can it continue its cancer vaccine success rally?

Bellwether Stocks Movement

Moderna Inc. Stock Climbs 8.5%, Outperforms Peers

Ultragenyx confirms FDA approval of Fayuvi

S&P 500 Top and Bottom Performing Stocks at About 03:30 P.m. EDT

Moderna Inc Stock (MRNA) Moved Up by 7.25% on Sep 17: Facts Behind the Movement

Moderna: Another Day, Another Big Stock Move. is the Cancer Vaccine Rally Back On?

Moderna Shares Hit Four-Week High; Last up 8%

THOMSON REUTERS

Nuvation Bio announces FDA approval of sNDA for Ibtrozi

Bayer receives FDA approval for Kerendia for CKD with type 1 diabetes

Moderna President Stephen Hoge Disposes of 80,575 Common Shares Worth $11.78 Million

Cboe data shows mixed options sentiment in Moderna with shares down 2.14%

ASX biotech expands diagnostics portfolio after FDA approval

Morning Star AU

Moderna CFO James M. Mock Disposes of 34,836 Common Shares Worth $4.68 Million

Biofrontera announces FDA approval of Ameluz supplemental new drug application

Scholar Rock Wins FDA Approval for SMA Therapy

Scholar Rock price target raised to $84 from $76 at BMO Capital

Telix Wins FDA Nod for First FET-PET Glioma Imaging Drug Pixclara

Scholar Rock announces FDA approval of isembyld

Moderna Inc. Stock Rallies 5.4%, Outperforms Peers

Pharming wins FDA nod to extend Joenja use to younger APDS children

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/MRNX/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"MRNX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MRNX\",,,,,undefined,":{"symbol":"MRNX","market":"US","secType":"STK","nameCN":"Defiance Daily Target 2X Long MRNA ETF","latestPrice":142.18,"timestamp":1791474589353,"preClose":142.97,"halted":0,"volume":86201,"delay":0,"changeRate":-0.005525634748548591,"floatShares":530000,"shares":530000,"eps":0,"marketStatus":"Trading","change":-0.79,"latestTime":"10-08 11:50:22 EDT","open":140.775,"high":147.06,"low":138.07,"amount":12222205.323280001,"amplitude":0.06288,"askPrice":141.59,"askSize":386,"bidPrice":140.14,"bidSize":386,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1791489600000},"marketStatusCode":2,"adr":0,"exchange":"ARCA","adjPreClose":142.97,"sharesOutstanding":30000,"nav":130.35,"aum":69085500,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":142.84,"preClose":142.97,"latestTime":"09:29 EDT","volume":3794,"amount":533542.4043599999,"timestamp":1791466158964,"change":-0.13,"changeRate":-0.000909,"amplitude":0.033294},"postHourTrading":{"tag":"盘后","latestPrice":141,"preClose":142.97,"latestTime":"19:58 EDT","volume":3978,"amount":562408.4827,"timestamp":1791417509147,"change":-1.97,"changeRate":-0.013779,"amplitude":0.023769},"volumeRatio":1.01321,"impliedVol":1.6904,"impliedVolPercentile":0.9677},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MRNX\",,,,,undefined,":{"symbol":"MRNX","floatShares":530000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.01321,"shares":530000,"dividePrice":0,"high":147.06,"amplitude":0.06288,"preClose":142.97,"low":138.07,"week52Low":14.95,"pbRate":"--","week52High":167.8902,"institutionHeld":0,"latestPrice":142.18,"eps":0,"divideRate":0,"volume":86201,"delay":0,"ttmEps":0,"open":140.775,"prevYearClose":20.61,"prevWeekClose":135.75,"prevMonthClose":140.98,"prevQuarterClose":140.98,"fiveDayClose":134.53,"twentyDayClose":73.84,"sixtyDayClose":38.81},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MRNX\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MRNX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MRNX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MRNX\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1120817782","title":"Moderna stock rises 8%: can it continue its cancer vaccine success rally?","url":"https://stock-news.laohu8.com/highlight/detail?id=1120817782","media":"Bellwether Stocks Movement","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120817782?lang=en_us&edition=fundamental","pubTime":"2026-09-18 14:04","pubTimestamp":1789711472,"startTime":"0","endTime":"0","summary":"","market":"us","thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/2014.webp","type":0,"news_type":0,"thumbnails":["https://news-video-sg.skytigris.cn/videos/covers/2014.webp"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNA","MRNX","MRNY"],"isVideo":true,"video":{"duration":64,"video_url":"https://news-video-sg.skytigris.cn/videos/remotion/2014/render_2014_1789704044919.mp4","video_thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/2014.webp","audio_url":"https://news-video-sg.skytigris.cn/videos/remotion/2014/tts/voiceover_4b258a41d147e8a5.mp3","isAI":true},"gpt_icon":0},{"id":"2668992940","title":"Moderna Inc. Stock Climbs 8.5%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2668992940","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668992940?lang=en_us&edition=fundamental","pubTime":"2026-09-18 04:33","pubTimestamp":1789677180,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. advanced 8.5% to $158.07 on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 1.7% to 26,418.30 and the Dow Jones Industrial Average rising 0.6% to 51,778.04.This was the stock's second consecutive day of gains.Moderna Inc. closed 10.5% short of its 52-week high of $176.66, which the company reached on August 19th.The stock outperformed some of its peers, as Johnson & Johnson rose 1.1% to $270.22, Pfizer Inc. rose 0.7% to $27.64, and Gilead Sciences Inc. rose 2.17% to $150.89.Trading volume totaled 19.1 million, compared to the 50-day average of 17.3 million.Data source: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TBXU","GNOM","IE00BZ1G4Q59.USD","IDNA","LU1061106388.HKD","TMED","LU2324357040.USD","LU0234570918.USD","BK4551","LU1037948897.HKD","LGHT","IE00BSNM7G36.USD","LU1778281490.HKD","WDNA","LU1674673428.USD","LU0122379950.USD","MRNX","LU0889565916.HKD","LU0114720955.EUR","LU0861579265.USD","BK4534","GILD","IBBQ","MRNA","MRNY","LU0320765992.SGD","LU0965509010.AUD","LU2089984988.USD","BMED","BIB","LU2357627491.SGD","BK4566","BK4568","BK4501","SG9999015945.SGD","LU0965509101.SGD","LU1585245621.USD","MEDI","BK4578","BBH","LU1934455863.HKD","LU0882574055.USD","LU0823416689.USD","LU1839511570.USD","SG9999015986.USD","LU0289739699.SGD","IE00B19Z3581.USD","IBB","IE00B7SZLL34.SGD","LU0859254822.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668994030","title":"Ultragenyx confirms FDA approval of Fayuvi","url":"https://stock-news.laohu8.com/highlight/detail?id=2668994030","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668994030?lang=en_us&edition=fundamental","pubTime":"2026-09-18 03:55","pubTimestamp":1789674924,"startTime":"0","endTime":"0","summary":"Ultragenyx (RARE) announced that the U.S. FDA granted standard full approval of Fayuvi, also known as UX111, for the treatment of pediatric patient...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ultragenyx-confirms-fda-approval-of-fayuvi-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ultragenyx-confirms-fda-approval-of-fayuvi-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FRTY","MRNX","BK4585","IDNA","MRNY","IBB","SYNB","GDOC","BBP","IYH","RARE","GNMX","NVIB","TECB","MEDI","LABU","XLVX","BK4588","TBXU","IEIH","BMED","PINK","PSCH","BK4139","LFSC","RSPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668299493","title":"S&P 500 Top and Bottom Performing Stocks at About 03:30 P.m. EDT","url":"https://stock-news.laohu8.com/highlight/detail?id=2668299493","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668299493?lang=en_us&edition=fundamental","pubTime":"2026-09-18 03:30","pubTimestamp":1789673408,"startTime":"0","endTime":"0","summary":"BUZZ - S&P 500 top and bottom performing stocks at about 03:30 p.m. EDTS&P 500.SPXTop PerformersPercent ChangeGenerac Holdings Inc.GNRC.N+18.8%Super Micro Computer IncSMCI.OQ+9.8%Intel CorpINTC.OQ+8.5%Hewlett Packard Enterprise CompanyHPE.N+8.4%Moderna, Inc.MRNA.OQ+7.4%Bottom PerformersPercent ChangeDaVita IncDVA.N-5.5%T-Mobile US IncTMUS.OQ-5.4%Builders FirstSource IncBLDR.N-3.8%Copart IncCPRT.OQ-3.6%Reddit, Inc.RDDT.N-3.4%As of 03:30 p.m., the S&P 500.SPXgained 85.76 points, or 1.14%, to 7,637.57 and had posted 12 new 52-week highs and 19 new lows.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260917:nL8N45922E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JEPI","LU2250418816.HKD","MOAT","ETFT","LU1988902786.USD","LU1064131342.USD","ALLW","RDTL","BK4529","BK4605","SSO","YSPY","LU2317271919.USD","GSLC","LU0056508442.USD","RSPU","LU2931357623.SGD","IE000BZT7R73.USD","BK4568","LU0006061336.USD","LU0208291251.USD","BK4559","LU1066051498.USD","GB00BDT5M118.USD","LU1506573853.SGD","LU2210149790.SGD","LU2089985449.USD","LU2360108059.USD","SMCL","LU2264538146.SGD","LU0310800379.SGD","SDS","SPDN","RDDC","SPLV","SOCL","XHB","IE0008368304.USD","SMCI","IE000M9KFDE8.USD","BK4612","LU0077335932.USD","BK4554","BK4579","DBSC","VOO","WDNA","LU0323240290.USD","VBK","SPYG","LU2360107168.USD","DMAX","BK4549","BK4527","LU0321505868.SGD","LU1861220033.SGD","SPXS","BK4196","LU0306806265.USD","LINT","BK4533","LU1066051225.USD","BK4561","RDDT","TMUS","SPMO","LU0266013472.USD","BK4535","LU0127658192.USD","LU2210150020.SGD","SMYY","BK4139","LU0225771236.USD","LU2384288077.EUR","SCHX","BK4602","IE000MB6IJN5.SGD","IJH","LU0225284248.USD","LU0353189763.USD","SPYM","LU1066051811.HKD","IE00BMPRXN33.USD","LU1814569148.SGD","RSPA","VV","LU0053671581.USD","BK4551","INTW","LU2361044865.SGD","LU1621767737.EUR","UPRO","LU1280957306.USD","LU0081259029.USD","LU0868494617.USD","LU1621767810.EUR","BK4585","GNRC","LU2092937221.SGD","LU0719512351.SGD","BK4132","LU1267930573.SGD","SPYQ","VTI","SMCY","LU0823414478.USD","HK0000304797.USD","LU2298321311.HKD","LU1303367103.USD","NOBL","LU0642271901.SGD","IE00B775SV38.USD","TTEQ","VTV","LU0321505439.SGD","LU0640476718.USD","SPXU","SPY","BK4137","VEU","LU0353189680.USD","LU2764263039.SGD","HIBS","BK4512","XDTE","CNRG","LU2720916845.USD","BK4588","SMCX","LU0154236417.USD","IJR","LU2764262908.HKD","SCHB","LU0276348264.USD","LU1878469433.USD","LU2087625088.SGD","MMAX","DVA","LU0048573561.USD","LU0274383776.USD","XLG","SMAX","ITOT","BK4548","INT","04335","MRNA","LU2360106780.USD","BK4534","LEGR","LU0348723411.USD","LU0742534661.SGD","LU2764263203.CNY","LU1035773651.USD","LU0149725797.USD","LU2041044095.USD","IVW","LU0251131958.USD","IE000F7OJYX1.SGD","SPXL","SOXX","SPGP","SPYD","XYLD","LGHT","LU0708994859.HKD","LU2357627491.SGD","BK4077","LU0859254822.USD","LU0128525929.USD","LU2543165471.USD","RSPN","SPUU","IVV","LU0061474705.USD","GPIX","CHPS","LU1861215975.USD","BK4141","MRNX","INTC","LU1066053197.SGD","SPUS","TSPY","IE000SO60NU8.SGD","IE000WAW04H5.SGD","BK4515","LU0029864427.USD","LU2249611893.SGD","BK4501","HIBL","VOOG","IE00BMPRXR70.SGD","DRIV","HK0000304805.HKD","LU0823421333.USD","LU0985481810.HKD","SPYH","LU1316542783.SGD","LU0082616367.USD","LU0323239441.USD","GNOM","LU2361044949.HKD","SPHQ","CPRT","BK4575","HPE","QQQA","LU0187121727.USD","FTXL","IDNA","AIQ","LU0320765489.SGD","SFY","BLDR","LU2394011477.USD","BMAY","LU2247934214.USD","LU2095319765.USD","ACWI","BK4086","LU0267386448.USD","LU1621768115.EUR","LU2461242641.AUD","BK4543","RSP","LU0070302665.USD","LU0170899867.USD","LU2098885051.SGD",".SPX","LU0314106906.USD","LU0786609619.USD","LU1983260115.SGD","SPHD","BK4096","SMCC","IE0000B7K699.USD","HPEL","BK4550","LU1852331112.SGD","BK4547","MRNY","SH","XNTK","LU2290526834.HKD","SPYV","LU0097036916.USD","LU2361045086.USD","LU0823421416.USD","LU0251142724.SGD","IE00BMPRXQ63.HKD","BK4170","LU2244417387.USD","LU0306807586.USD","INYY","IE00B3S45H60.SGD","RDYY","SPYU","LU1069347547.HKD","BK4532","SMCZ","AIS","SINTCmain","IVE","LU2148611432.USD","LU1621768206.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668913409","title":"Moderna Inc Stock (MRNA) Moved Up by 7.25% on Sep 17: Facts Behind the Movement","url":"https://stock-news.laohu8.com/highlight/detail?id=2668913409","media":"TradingKey","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668913409?lang=en_us&edition=fundamental","pubTime":"2026-09-18 01:15","pubTimestamp":1789665324,"startTime":"0","endTime":"0","summary":"• Macroeconomic tailwinds and risk-on sentiment drove Moderna's strong upward rally and volatility.\n• Positive late-stage clinical data for intismeran expanded valuation expectations for oncology.\n• Analyst upgrades and institutional demand absorbed selling pressure from routine insider sales.","market":"hk","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262173707-market-movers-mrna-20260917","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNX","BK4588","MRNY","BK4568","BK4532","BK4533","BK4534","BK4585","BK4551","LGHT","BK4501","BK4139","BK4548","MRNA","GNOM","IDNA","WDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668999880","title":"Moderna: Another Day, Another Big Stock Move. is the Cancer Vaccine Rally Back On?","url":"https://stock-news.laohu8.com/highlight/detail?id=2668999880","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668999880?lang=en_us&edition=fundamental","pubTime":"2026-09-18 00:32","pubTimestamp":1789662720,"startTime":"0","endTime":"0","summary":"Moderna stock abruptly rallied on Thursday, pacing toward its best session since a positive update for its experimental cancer vaccine sent shares skyrocketing.Look to no other explanation than a mome","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PAWZ","LU1934455277.USD","LU0069063385.USD","GDOC","HRTS","BMED","PPH","RXL","LU1571399168.USD","MRK","LU0965509283.SGD","IE00B1BXHZ80.USD","MRNY","MRNX","LU0861579265.USD","LU2106854487.HKD","LU1032466523.USD","LU1983299246.USD","WDNA","BK4534","LU0124676726.USD","LU1974910355.USD","IYH","MRNA","SGXZ57979304.SGD","TRUH","SG9999014575.USD","BK4551","LU0211331839.USD","IDNA","GNOM","LU0162691827.USD","LU1037948897.HKD","LU1162221912.USD","FHLC","IXJ","LU1201861249.SGD","SG9999001176.USD","VHT","XLV","JDOC","LU2125909593.SGD","LU2125909247.SGD","IE00BN8TJ469.HKD","LU2491050071.SGD","LGHT","IHE","SG9999013999.USD","FTXH","LU0122379950.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668399537","title":"Moderna Shares Hit Four-Week High; Last up 8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2668399537","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668399537?lang=en_us&edition=fundamental","pubTime":"2026-09-17 23:09","pubTimestamp":1789657789,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260917:nL4N4591AO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["WDNA","BK4534","BK4501","BK4551","BK4139","BK4568","BK4588","GNOM","BK4532","BK4548","MRNA","MRNX","BK4585","MRNY","LGHT","BK4533","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668996120","title":"Nuvation Bio announces FDA approval of sNDA for Ibtrozi","url":"https://stock-news.laohu8.com/highlight/detail?id=2668996120","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668996120?lang=en_us&edition=fundamental","pubTime":"2026-09-17 19:35","pubTimestamp":1789644932,"startTime":"0","endTime":"0","summary":"Nuvation Bio (NUVB) announced that the U.S. FDA has approved a supplemental New Drug Application for Ibtrozi, a ROS1 inhibitor approved for the tre...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/nuvation-bio-announces-fda-approval-of-snda-for-ibtrozi-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/nuvation-bio-announces-fda-approval-of-snda-for-ibtrozi-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IDNA","MRNY","BK4585","IYH","PSCH","LABU","BK4588","BBP","XLVX","IEIH","RSPH","BK4007","TBXU","MEDI","GDOC","FRTY","NVIB","IBB","TECB","PINK","LFSC","NUVB","MRNX","BMED","GNMX","SYNB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668963474","title":"Bayer receives FDA approval for Kerendia for CKD with type 1 diabetes","url":"https://stock-news.laohu8.com/highlight/detail?id=2668963474","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668963474?lang=en_us&edition=fundamental","pubTime":"2026-09-17 17:30","pubTimestamp":1789637420,"startTime":"0","endTime":"0","summary":"Bayer (BAYRY) announced that theFDA approved Kerendia to reduce urinary albumin-to-creatinine ratio, which is expected to reduce the risk of sustai...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bayer-receives-fda-approval-for-kerendia-for-ckd-with-type-1-diabetes-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bayer-receives-fda-approval-for-kerendia-for-ckd-with-type-1-diabetes-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RSPH","MEDI","BBP","SYNB","TBXU","IYH","BMED","IDNA","GNMX","GDOC","FRTY","MRNY","BAYRY","PSCH","BK4007","LABU","TECB","XLVX","BK4585","NVIB","MRNX","IBB","LFSC","BK4588","PINK","IEIH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668109935","title":"Moderna President Stephen Hoge Disposes of 80,575 Common Shares Worth $11.78 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2668109935","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668109935?lang=en_us&edition=fundamental","pubTime":"2026-09-17 04:49","pubTimestamp":1789591761,"startTime":"0","endTime":"0","summary":"Moderna President Stephen Hoge disposes of 80,575 common shares worth $11.78 millionModerna President Stephen Hoge cut his direct common-stock stake to 1,562,029 shares via option exercises, then sale","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nNDL32Fyc6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNX","BK4588","MRNY","BK4568","BK4532","BK4533","BK4534","BK4585","BK4551","LGHT","BK4501","BK4139","BK4548","MRNA","GNOM","IDNA","WDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667214586","title":"Cboe data shows mixed options sentiment in Moderna with shares down 2.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2667214586","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667214586?lang=en_us&edition=fundamental","pubTime":"2026-09-16 02:50","pubTimestamp":1789498212,"startTime":"0","endTime":"0","summary":"Cboe data shows mixed options sentiment in Moderna (MRNA), with shares down $3.15 near $143.54. Options volume relatively light with 39k contracts ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cboe-data-shows-mixed-options-sentiment-in-moderna-with-shares-down-2-14-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cboe-data-shows-mixed-options-sentiment-in-moderna-with-shares-down-2-14-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MRNY","BK4588","LGHT","BK4534","IDNA","BK4585","GNOM","BK4501","BK4568","BK4533","BK4532","MRNA","BK4551","WDNA","MRNX","BK4548","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667671746","title":"ASX biotech expands diagnostics portfolio after FDA approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2667671746","media":"Morning Star AU","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667671746?lang=en_us&edition=fundamental","pubTime":"2026-09-16 00:00","pubTimestamp":1789488000,"startTime":"0","endTime":"0","summary":"Telix Pharmaceutical’s (ASX.TLX) Pixclara becomes the first positron emission tomography, or PET, imaging agent for glioma brain cancer to receive approval from the US Food and Drug Administration.Why","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"morningstar_stock","url":"https://www.morningstar.com.au/stocks/asx-biotech-expands-diagnostics-portfolio-after-fda-approval","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.morningstar.com.au/stocks/asx-biotech-expands-diagnostics-portfolio-after-fda-approval","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"morningstar_stock","symbols":["IBB","MRNX","GDOC","IYH","FRTY","IEIH","LFSC","XBIX","TECB","MEDI","NVIB","TBXU","LABU","SYNB","RSPH","IDNA","GNMX","PINK","PSCH","MRNY","BMED","BK4588","BBP","XLVX","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667695518","title":"Moderna CFO James M. Mock Disposes of 34,836 Common Shares Worth $4.68 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2667695518","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667695518?lang=en_us&edition=fundamental","pubTime":"2026-09-15 04:25","pubTimestamp":1789417559,"startTime":"0","endTime":"0","summary":"Moderna CFO James M. Mock disposes of 34,836 common shares worth $4.68 millionModerna CFO Mock James M disclosed sales of 34,836 common shares on Sep. 10, 2026 at USD 134.49.He also exercised stock op","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nNDL8rXTDg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Moderna CFO James M. Mock Disposes of 34,836 Common Shares Worth $4.68 Million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IDNA","MRNA","MRNX","BK4533","BK4568","GNOM","BK4551","BK4139","LGHT","BK4534","BK4548","BK4501","BK4588","MRNY","BK4532","WDNA","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667661630","title":"Biofrontera announces FDA approval of Ameluz supplemental new drug application","url":"https://stock-news.laohu8.com/highlight/detail?id=2667661630","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667661630?lang=en_us&edition=fundamental","pubTime":"2026-09-14 21:35","pubTimestamp":1789392922,"startTime":"0","endTime":"0","summary":"Biofrontera (BFRI) announced that the FDA has approved the company’s supplemental new drug application, or sNDA, for Ameluz topical gel, 10%, in co...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/biofrontera-announces-fda-approval-of-ameluz-supplemental-new-drug-application-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/biofrontera-announces-fda-approval-of-ameluz-supplemental-new-drug-application-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MRNY","LABU","FRTY","LFSC","IYH","PSCH","BBP","SYNB","IBB","XLVX","BK4588","TBXU","PINK","MEDI","BK4585","TECB","BMED","NVIB","GNMX","BK4007","MRNX","RSPH","IEIH","GDOC","BFRI","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667066661","title":"Scholar Rock Wins FDA Approval for SMA Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2667066661","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667066661?lang=en_us&edition=fundamental","pubTime":"2026-09-14 20:32","pubTimestamp":1789389127,"startTime":"0","endTime":"0","summary":"The latest update is out from Scholar Rock Holding ( ($SRRK) ). On September 11, 2026, Scholar Rock announced U.S. FDA approval of ISEMBYLD (apiteg...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/scholar-rock-wins-fda-approval-for-sma-therapy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/scholar-rock-wins-fda-approval-for-sma-therapy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TBXU","XLVX","BK4585","PINK","LFSC","IEIH","GNMX","MRNY","FRTY","BK4588","GDOC","PSCH","BMED","BBP","IBB","MEDI","LABU","MRNX","IDNA","IYH","SYNB","NVIB","TECB","RSPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667134663","title":"Scholar Rock price target raised to $84 from $76 at BMO Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2667134663","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667134663?lang=en_us&edition=fundamental","pubTime":"2026-09-14 19:36","pubTimestamp":1789385772,"startTime":"0","endTime":"0","summary":"BMO Capital raised the firm’s price target on Scholar Rock (SRRK) to $84 from $76 and keeps an Outperform rating on the shares. The FDA approval of...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/scholar-rock-price-target-raised-to-84-from-76-at-bmo-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/scholar-rock-price-target-raised-to-84-from-76-at-bmo-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GDOC","FRTY","THNR","BK4585","XLVX","LFSC","BMED","SRRK","MRNY","LABU","TBXU","TECB","SYNB","BK4588","IBRN","NVIB","PINK","PSCH","BBP","IYH","GNMX","MEDI","IBB","IEIH","MRNX","RSPH","IDNA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667635862","title":"Telix Wins FDA Nod for First FET-PET Glioma Imaging Drug Pixclara","url":"https://stock-news.laohu8.com/highlight/detail?id=2667635862","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667635862?lang=en_us&edition=fundamental","pubTime":"2026-09-14 06:54","pubTimestamp":1789340092,"startTime":"0","endTime":"0","summary":"The latest update is out from Telix Pharmaceuticals ( ($AU:TLX) ). Telix Pharmaceuticals has secured U.S. FDA approval for Pixclara, the first FET-...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/telix-wins-fda-nod-for-first-fet-pet-glioma-imaging-drug-pixclara?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/telix-wins-fda-nod-for-first-fet-pet-glioma-imaging-drug-pixclara?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RSPH","BK4588","BK4179","LFSC","GNMX","IBB","TECB","PINK","PSCH","XLVX","TLX","SYNB","TBXU","BK4585","GDOC","MRNX","FRTY","BMED","NVIB","MRNY","IDNA","FET","IYH","IEIH","BK4139","MEDI","LABU","BBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666577803","title":"Scholar Rock announces FDA approval of isembyld","url":"https://stock-news.laohu8.com/highlight/detail?id=2666577803","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666577803?lang=en_us&edition=fundamental","pubTime":"2026-09-12 06:30","pubTimestamp":1789165818,"startTime":"0","endTime":"0","summary":"Scholar Rock (SRRK) announced that the FDA has approved isembyld for the treatment of spinal muscular atrophy in adults and children two years of a...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/scholar-rock-announces-fda-approval-of-isembyld-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/scholar-rock-announces-fda-approval-of-isembyld-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TBXU","XLVX","BK4585","PINK","LFSC","IEIH","BK4139","GNMX","MRNY","BK4588","FRTY","GDOC","PSCH","THNR","BMED","BBP","IBB","SRRK","MEDI","LABU","MRNX","IDNA","IYH","SYNB","NVIB","IBRN","TECB","RSPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666574302","title":"Moderna Inc. Stock Rallies 5.4%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2666574302","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666574302?lang=en_us&edition=fundamental","pubTime":"2026-09-12 04:33","pubTimestamp":1789158780,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. advanced 5.4% to $143.97 on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 1.0% to 26,333.04 and the Dow Jones Industrial Average rising 1.0% to 52,573.29.This was the stock's second consecutive day of gains.Moderna Inc. closed 18.5% short of its 52-week high of $176.66, which the company achieved on August 19th.The stock outperformed some of its peers, as Johnson & Johnson fell 0.3% to $265.58, Pfizer Inc. rose 0.3% to $27.72, and Gilead Sciences Inc. fell 0.75% to $143.72.Trading volume totaled 15.3 million, compared to the 50-day average of 17.4 million.Data source: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","BK4534","MRNY","BBH","IBBQ","BK4139","LU1674673691.USD","IE00B19Z3581.USD","TMED","MRNA","IBB","LU0861579265.USD","BK4588","LU0965509101.SGD","IE00BKVL7J92.USD","SG9999015986.USD","TBXU","SG9999015978.USD","LU0965508806.USD","MEDI","LU0889565916.HKD","LU0114720955.EUR","LU0058720904.USD","GNOM","LU1934455277.USD","IE00BSNM7G36.USD","BK4548","LU0965509283.SGD","BIB","LU1571399168.USD","BMED","LU1585245621.USD","IE00B3T34201.USD","LU1674673428.USD","WDNA","MRNX","LU0289739699.SGD","LU1430594728.SGD","LU2357627491.SGD","SG9999015952.SGD","LU2468319806.SGD","LU1057294990.SGD","BK4568","LU0965509010.AUD","LU1066051498.USD","IDNA","LGHT","BK4578","LU1778281490.HKD","GILD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666795715","title":"Pharming wins FDA nod to extend Joenja use to younger APDS children","url":"https://stock-news.laohu8.com/highlight/detail?id=2666795715","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666795715?lang=en_us&edition=fundamental","pubTime":"2026-09-12 02:32","pubTimestamp":1789151567,"startTime":"0","endTime":"0","summary":"Pharming Group ( ($NL:PHARM) ) has provided an announcement. Pharming has secured U.S. FDA approval for new 40 mg and 50 mg twice-daily doses of Jo...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pharming-wins-fda-nod-to-extend-joenja-use-to-younger-apds-children?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pharming-wins-fda-nod-to-extend-joenja-use-to-younger-apds-children?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLVX","GDOC","PSCH","SYNB","PINK","MRNY","NVIB","BMED","LABU","LFSC","IEIH","TBXU","IBB","IYH","IDNA","BK4588","GNMX","MRNX","BK4585","RSPH","FRTY","MEDI","TECB","BBP"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":7,"totalSize":200,"code":"91000000","status":"200"}]}}